1. Bozkurt B, Colvin M, Cook J, Cooper LT,
Deswal A, Fonarow GC, Francis GS,
Lenihan D, Lewis EF, McNamara DM,
Pahl E, Vasan RS, Ramasubbu K,
Rasmusson K, Towbin JA, Yancy C,
American Heart Association Committee
on Heart F, Transplantation of the Council on Clinical C, Council on Cardiovascular Disease in the Y, Council on C,
Stroke N, Council on E, Prevention,
Council on Quality of C, Outcomes R.
Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the
American Heart Association. Circulation
2016; 134: e579–e646.
2. Becker MAJ, Cornel JH, van de Ven PM,
van Rossum AC, Allaart CP, Germans T.
The
prognostic
value
of
late
gadolinium-enhanced cardiac magnetic
resonance imaging in nonischemic dilated cardiomyopathy: a review and
meta-analysis. JACC Cardiovasc Imaging
2018; 11: 1274–1284.
3. Lund LH, Edwards LB, Kucheryavaya AY,
Dipchand AI, Benden C, Christie JD,
Dobbels F, Kirk R, Rahmel AO, Yusen
RD, Stehlik J, International Society for
H, Lung T. The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart
transplant report—2013; focus theme:
age. J Heart Lung Transplant 2013; 32:
951–964.
4. Nakatani T, Fukushima N, Ono M, Saiki
Y, Matsuda H, Nunoda S, Sawa Y, Isobe
M. The registry report of heart transplantation in Japan (1999-2014). Circ J
2016; 80: 44–50.
5. Kubanek M, Sramko M, Maluskova J,
Kautznerova D, Weichet J, Lupinek P,
Vrbska J, Malek I, Kautzner J. Novel
ESC Heart Failure 2021; 8: 1359–1368
DOI: 10.1002/ehf2.13216
20555822, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13216 by Cochrane Japan, Wiley Online Library on [16/11/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1366
6.
7.
8.
9.
10.
11.
12.
13.
14.
predictors of left ventricular reverse
remodeling
in
individuals
with
recent-onset dilated cardiomyopathy. J
Am Coll Cardiol 2013; 61: 54–63.
Merlo M, Pyxaras SA, Pinamonti B,
Barbati G, Di Lenarda A, Sinagra G.
Prevalence and prognostic significance
of left ventricular reverse remodeling
in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll
Cardiol 2011; 57: 1468–1476.
Verdonschot JAJ, Hazebroek MR, Wang
P, Sanders-van Wijk S, Merken JJ,
Adriaansen YA, van den Wijngaard A,
Krapels IPC, Brunner-La Rocca HP,
Brunner HG, Heymans SRB. Clinical
phenotype and genotype associations
with improvement in left ventricular
function in dilated cardiomyopathy. Circ
Heart Fail 2018; 11: e005220.
Kawai K, Takaoka H, Hata K, Yokota Y,
Yokoyama M. Prevalence, predictors,
and prognosis of reversal of maladaptive
remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy. Am J Cardiol 1999; 84: 671–676.
Tayal U, Wage R, Newsome S,
Manivarmane R, Izgi C, Muthumala A,
Dungu JN, Assomull R, Hatipoglu S,
Halliday BP, Lota AS, Ware JS, Gregson
J, Frenneaux M, Cook SA, Pennell DJ,
Scott AD, Cleland JGF, Prasad SK. Predictors of left ventricular remodelling
in patients with dilated cardiomyopathy
—a cardiovascular magnetic resonance
study. Eur J Heart Fail 2020; 22:
1160–1170.
Choi JO, Kim EY, Lee GY, Lee SC, Park
SW, Kim DK, Oh JK, Jeon ES. Predictors
of left ventricular reverse remodeling
and subsequent outcome in nonischemic
dilated cardiomyopathy. Circ J 2013; 77:
462–469.
Ko T, Fujita K, Nomura S, Uemura Y,
Yamada S, Tobita T, Katoh M, Satoh M,
Ito M, Domoto Y, Hosoya Y, Amiya E,
Hatano M, Morita H, Fukayama M,
Aburatani H, Komuro I. Quantification
of DNA damage in heart tissue as a novel
prediction tool for therapeutic prognosis
of patients with dilated cardiomyopathy.
JACC Basic Transl Sci 2019; 4: 670–680.
Ishii S, Inomata T, Fujita T, Iida Y, Ikeda
Y, Nabeta T, Yanagisawa T, Naruke T,
Mizutani T, Koitabashi T, Takeuchi I,
Ako J. Clinical significance of
endomyocardial biopsy in conjunction
with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling
in
idiopathic
dilated
cardiomyopathy. Heart Vessels 2016; 31:
1960–1968.
Amorim S, Campelo M, Martins E,
Moura B, Sousa A, Pinho T, SilvaCardoso J, Maciel MJ. Prevalence,
predictors and prognosis of ventricular
reverse remodeling in idiopathic dilated
cardiomyopathy. Rev Port Cardiol 2016;
35: 253–260.
Tobita T, Nomura S, Fujita T, Morita H,
Asano Y, Onoue K, Ito M, Imai Y, Suzuki
A, Ko T, Satoh M, Fujita K, Naito AT,
15.
16.
17.
18.
19.
20.
21.
22.
Furutani Y, Toko H, Harada M, Amiya
E, Hatano M, Takimoto E, Shiga T,
Nakanishi T, Sakata Y, Ono M, Saito Y,
Takashima S, Hagiwara N, Aburatani H,
Komuro I. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse
remodeling. Sci Rep 2018; 8: 1998.
Nabeta T, Inomata T, Fujita T, Iida Y,
Ikeda Y, Sato T, Ishii S, Maekawa E,
Mizutani T, Naruke T, Koitabashi T,
Inoue Y, Ako J. Temporal change of myocardial tissue character is associated
with left ventricular reverse remodeling
in patients with dilated cardiomyopathy:
a cardiovascular magnetic resonance
study. J Cardiol 2017; 70: 185–191.
Hazebroek MR, Moors S, Dennert R, van
den Wijngaard A, Krapels I, Hoos M,
Verdonschot J, Merken JJ, de Vries B,
Wolffs PF, Crijns HJ, Brunner-La Rocca
HP, Heymans S. Prognostic relevance of
gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification. J
Am Coll Cardiol 2015; 66: 1313–1323.
Morimoto R, Okumura T, Hirashiki A,
Ishii H, Ichii T, Aoki S, Furusawa K,
Hiraiwa H, Kondo T, Watanabe N, Kano
N, Fukaya K, Sawamura A, Takeshita K,
Bando YK, Murohara T. Myocardial contractile reserve predicts left ventricular
reverse remodeling and cardiac events
in dilated cardiomyopathy. J Cardiol
2017; 70: 303–309.
Lang RM, Badano LP, Mor-Avi V, Afilalo
J, Armstrong A, Ernande L, Flachskampf
FA, Foster E, Goldstein SA, Kuznetsova
T, Lancellotti P, Muraru D, Picard MH,
Rietzschel ER, Rudski L, Spencer KT,
Tsang W, Voigt JU. Recommendations
for cardiac chamber quantification by
echocardiography in adults: an update
from the American Society of Echocardiography and the European Association
of Cardiovascular Imaging. J Am Soc
Echocardiogr 2015; 28: 1–39.
Fukaya K, Takeshita K, Okumura T,
Hiraiwa H, Aoki S, Ichii T, Sugiura Y,
Kitagawa K, Kondo T, Watanabe N, Kano
N, Furusawa K, Sawamura A, Morimoto
R, Bando Y, Murohara T. Sokolow-Lyon
voltage is suitable for monitoring improvement in cardiac function and prognosis of patients with idiopathic dilated
cardiomyopathy.
Ann
Noninvasive
Electrocardiol 2017; 22: e12431.
Merlo M, Caiffa T, Gobbo M, Adamo L,
Sinagra G. Reverse remodeling in dilated cardiomyopathy: insights and future perspectives. Int J Cardiol Heart
Vasc 2018; 18: 52–57.
Moretti M, Merlo M, Barbati G, Di
Lenarda A, Brun F, Pinamonti B, Gregori
D, Mestroni L, Sinagra G. Prognostic impact of familial screening in dilated cardiomyopathy. Eur J Heart Fail 2010; 12:
922–927.
Meyer S, Van Der Meer P, Van Tintelen
JP, Van Den Berg MP. Sex differences in
cardiomyopathies. Eur J Heart Fail
2014; 16: 238–247.
1367
23. Van Spaendonck-Zwarts KY, Van
Rijsingen IAW, Van Den Berg MP,
Lekanne Deprez RH, Post JG, Van Mil
AM, Asselbergs FW, Christiaans I, Van
Langen IM, Wilde AAM, De Boer RA,
Jongbloed JDH, Pinto YM, Van Tintelen
JP. Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years’
experience. Eur J Heart Fail 2013; 15:
628–636.
24. Marume K, Noguchi T, Tateishi E, Morita
Y, Miura H, Nishimura K, Ohta-Ogo K,
Yamada N, Tsujita K, Izumi C, Kusano K,
Ogawa H, Yasuda S. Prognosis and clinical characteristics of dilated cardiomyopathy with family history via pedigree
analysis. Circ J 2020; 84: 1284–1293.
25. Steimle AE, Stevenson LW, Fonarow GC,
Hamilton MA, Moriguchi JD. Prediction
of improvement in recent onset cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol 1994; 23:
553–559.
26. Rubis P, Wisniowska-Smialek S,
Wypasek E, Biernacka-Fijalkowska B,
Rudnicka-Sosin L, Dziewiecka E, Faltyn
P, Khachatryan L, Karabinowska A,
Kozanecki A, Tomkiewicz-Pajak L,
Podolec P. Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of
collagen metabolism in dilated cardiomyopathy. Inflamm Res 2016; 65:
941–949.
27. Cannatà A, De Angelis G, Boscutti A,
Normand C, Artico J, Gentile P, Zecchin
M, Heymans S, Merlo M, Sinagra G. Arrhythmic
risk
stratification
in
non-ischaemic dilated cardiomyopathy
beyond ejection fraction. Heart 2020;
106: 656–664.
28. Marume K, Noguchi T, Tateishi E, Morita
Y, Kamakura T, Ishibashi K, Noda T,
Miura H, Nishimura K, Nakai M, Yamada
N, Tsujita K, Anzai T, Kusano K, Ogawa
H, Yasuda S. Mortality and sudden cardiac death risk stratification using the
noninvasive combination of wide QRS
duration and late gadolinium enhancement in idiopathic dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2018;
11: e006233.
29. Ikeda Y, Inomata T, Fujita T, Iida Y,
Nabeta T, Ishii S, Maekawa E,
Yanagisawa T, Mizutani T, Naruke T,
Koitabashi T, Takeuchi I, Ako J. Cardiac
fibrosis detected by magnetic resonance
imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated
cardiomyopathy. Heart Vessels 2016; 31:
1817–1825.
30. Priori SG, Blomstrom-Lundqvist C,
Mazzanti A, Blom N, Borggrefe M,
Camm J, Elliott PM, Fitzsimons D,
Hatala R, Hindricks G, Kirchhof P,
Kjeldsen K, Kuck KH, HernandezMadrid A, Nikolaou N, Norekval TM,
Spaulding C, Van Veldhuisen DJ, Group
ESCSD. 2015 ESC Guidelines for the
management
of
patients
with
ESC Heart Failure 2021; 8: 1359–1368
DOI: 10.1002/ehf2.13216
20555822, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13216 by Cochrane Japan, Wiley Online Library on [16/11/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
A clinical score for predicting LVRR in patients with DCM
ventricular arrhythmias and the prevention of sudden cardiac death: the task
force for the management of patients
with ventricular arrhythmias and the
prevention of sudden cardiac death of
the European Society of Cardiology
(ESC). Endorsed by: Association for
European Paediatric and Congenital
Cardiology (AEPC). Eur Heart J 2015;
36: 2793–2867.
31. Topkara VK, Garan AR, Fine B, GodierFurnémont AF, Breskin A, Cagliostro B,
Yuzefpolskaya M, Takeda K, Takayama
H, Mancini DM, Naka Y, Colombo PC.
Myocardial recovery in patients receiving contemporary left ventricular assist
Y. Kimura et al.
devices: results from the Interagency
Registry for Mechanically Assisted Circulatory Support (INTERMACS). Circ
Heart Fail 2016; 9: e003157.
32. D’Ambrosio A, Patti G, Manzoli A,
Sinagra G, Di Lenarda A, Silvestri F, Di
Sciascio G. The fate of acute myocarditis
between spontaneous improvement and
evolution to dilated cardiomyopathy: a
review. Heart 2001; 85: 499–504.
33. Tschöpe C, Ammirati E, Bozkurt B,
Caforio ALP, Cooper LT, Felix SB, Hare
JM, Heidecker B, Heymans S, Hübner
N, Kelle S, Klingel K, Maatz H, Parwani
AS, Spillmann F, Starling RC, Tsutsui
H, Seferovic P, Van Linthout S.
Myocarditis and inflammatory cardiomyopathy: current evidence and future
directions. Nat Rev Cardiol 2020;Oct
12: 1–25. https://doi.org/10.1038/
s41569-020-00435-x
34. Ammirati E, Frigerio M, Adler ED, Basso
C, Birnie DH, Brambatti M, Friedrich
MG, Klingel K, Lehtonen J, Moslehi JJ,
Pedrotti P, Rimoldi OE, Schultheiss HP,
Tschöpe C, Cooper LT Jr, Camici PG.
Management of acute myocarditis and
chronic inflammatory cardiomyopathy:
an expert consensus document. Circ
Heart Fail 2020; 13: e007405.
ESC Heart Failure 2021; 8: 1359–1368
DOI: 10.1002/ehf2.13216
20555822, 2021, 2, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13216 by Cochrane Japan, Wiley Online Library on [16/11/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
1368
...
論文の公開元へ
